Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | F10 | P00742 | 2/20 | 0.35 |
| ▸ | MAOB | P27338 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | GHSR | Q92847 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | NSD2 | O96028 | 1/20 | 0.34 |
| ▸ | DRD2 | P14416 | 2/20 | 0.34 |
| ▸ | DRD4 | P21917 | 2/20 | 0.34 |
| ▸ | DRD3 | P35462 | 2/20 | 0.34 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.34 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.34 |
| ▸ | GPR139 | Q6DWJ6 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22327316 | 0.93 | GAA (0.40) | ALDH1A1KMT2AHTTSMN1; SMN2F10 | |
| SCHEMBL26068676 | 0.93 | MAOB (0.36) | ALDH1A1KMT2AHTTSMN1; SMN2F10 | |
| SCHEMBL22598488 | 0.88 | ALDH1A1 (0.35) | ALDH1A1KMT2AHTTSMN1; SMN2MAOB | |
| SCHEMBL22327218 | 0.88 | ALDH1A1 (0.35) | ALDH1A1KMT2AHTTSMN1; SMN2MAOB | |
| SCHEMBL22598389 | 0.88 | ALDH1A1 (0.35) | ALDH1A1KMT2AHTTSMN1; SMN2MAOB | |
| SCHEMBL22327213 | 0.88 | ALDH1A1 (0.35) | ALDH1A1KMT2AHTTSMN1; SMN2MAOB | |
| SCHEMBL22598408 | 0.88 | ALDH1A1 (0.35) | ALDH1A1KMT2AHTTSMN1; SMN2MAOB | |
| SCHEMBL22327071 | 0.88 | ALDH1A1 (0.35) | ALDH1A1KMT2AHTTSMN1; SMN2MAOB | |
| SCHEMBL22598364 | 0.88 | ALDH1A1 (0.35) | ALDH1A1KMT2AHTTSMN1; SMN2MAOB | |
| SCHEMBL22327242 | 0.88 | ALDH1A1 (0.35) | ALDH1A1KMT2AHTTSMN1; SMN2MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230203083-A1 | NUCLEOTIDE ANALOGUES | FIRST-CITIZENS BANK & TRUST COMPANY | 2023-06-29 | — | — | US | disclosed |
| US-20230028359-A1 | NUCLEOTIDE ANALOGUES | FIRST-CITIZENS BANK & TRUST COMPANY | 2023-01-26 | — | — | US | disclosed |
| US-20230002436-A1 | MODIFIED NUCLEOTIDES AND USES THEREOF | FIRST-CITIZENS BANK & TRUST COMPANY | 2023-01-05 | — | — | US | disclosed |
| US-11174281-B1 | Modified nucleotides and uses thereof | Singular Genomics Systems, Inc. (US) | 2021-11-16 | — | — | US | disclosed |
| US-10738072-B1 | Nucleotide analogues | Singular Genomics Systems, Inc. (US) | 2020-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230002436-A1 | MODIFIED NUCLEOTIDES AND USES THEREOF | NUDT1, RNMT, ADAR | ALDH1A1 1149/4885KMT2A 1548/4885HTT 1240/4885 |
| US-11174281-B1 | Modified nucleotides and uses thereof | NUDT1, RNMT, ADAR | ALDH1A1 1149/4885KMT2A 1548/4885HTT 1240/4885 |
| US-20230028359-A1 | NUCLEOTIDE ANALOGUES | ITPA, POLB, NUDT1 | ALDH1A1 1313/4885KMT2A 1334/4885HTT 1263/4885 |
| US-10738072-B1 | Nucleotide analogues | NUDT1, POLN, TYMP | ALDH1A1 1629/4885KMT2A 2130/4885HTT 1171/4885 |
| US-20230203083-A1 | NUCLEOTIDE ANALOGUES | ITPA, POLB, NUDT1 | ALDH1A1 1313/4885KMT2A 1334/4885HTT 1263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.